my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
23-05-2012: A EUROSTARS grant of €2.1 million has been awarded to a transnational consortium consisting of Khondrion BV ( Nijmegen), Radboud University Nijmegen Medical Centre (RUNMC, Nijmegen), Pharmacelsus GmbH (Saarbruecken) and ElexoPharm GmbH (Saarbruecken). This grant, which for the German partners comes from the German Federal Ministry of Education and Research (BMBF), will support an ambitious scientific collaboration to discover treatments for mitochondrial diseases with high unmet medical need (approximately 300,000 patients in industrialized countries).
During the three years’ grant period, each partner of this multidisciplinary European consortium will contribute its expertise to reach their shared goal. ElexoPharm is responsible for the design and synthesis of small pharmaceutical molecules with state of the art in silico modelling and medicinal chemistry technologies. Khondrion acts as the consortium leader and will carry out the in vitro evaluation of the new chemical entities, including screening in their cell-based mitochondrial disease models. Pharmacelsus is going to perform ADME, toxicity and PK studies in their GLP-certified facilities, and the RUNMC will evaluate the best compounds regarding in vivo efficacy in preclinical studies to achieve Proof of Principle.
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
ElexoPharm Receives € 2.1 Million EUROSTARS Grant
A EUROSTARS grant of €2.1 million has been awarded to a transnational consortium consisting of Khondrion BV ( Nijmegen), Radboud University Nijmegen Medical Centre (RUNMC, Nijmegen), Pharmacelsus GmbH (Saarbruecken) and ElexoPharm GmbH (Saarbruecken). This grant, which for the German partne ... more
ElexoPharm Appoints Dr. Chris J. van Koppen as Head of Research
ElexoPharm GmbH announces the appointment of Dr. Chris J. van Koppen as Head of Research. He will lead the preclinical drug discovery projects of ElexoPharm and will build further alliances with larger pharmaceutical companies. Dr. van Koppen holds a Ph.D. in Pharmacology and brings extensi ... more
ElexoPharm Appoints Prof. Jürgen Engel as Chairman of the Advisory Board
ElexoPharm GmbH announced the appointment of Professor Dr. Jürgen Engel as Chairman of its Advisory Board. He is going to support ElexoPharm’s efforts to expand its activities in preclinical drug development and to build up strong alliances with big pharmaceutical companies. As Chairman of ... more
ElexoPharm Receives € 2.1 Million EUROSTARS Grant
A EUROSTARS grant of €2.1 million has been awarded to a transnational consortium consisting of Khondrion BV ( Nijmegen), Radboud University Nijmegen Medical Centre (RUNMC, Nijmegen), Pharmacelsus GmbH (Saarbruecken) and ElexoPharm GmbH (Saarbruecken). This grant, which for the German partne ... more
New Hope in Fight Against the Flu
Pharmacelsus GmbH announces its participation in the 4 year multi-national research cooperation project “FLUCURE” supported by the European Union with the goal of developing novel, small molecule based therapeutics for respiratory diseases caused by influenza viruses. The consortium also jo ... more
Pharmacelsus’ GLP implementation exemplary for European CROs
Pharmacelsus obtained GLP-certification covering the complete portfolio in November 2008. The company is not only able to perform accompanying analytical services for clinical studies in addition to its preclinical services, but also decided to share its knowledge on the GLP implementation ... more
Pharmacelsus is a preclinical CRO providing pharmacological, biological and bioanalytical test services in vitro and in vivo for the pharmaceutical and biotechnological industry. Pharmacelsus offers to its customers services in the following areas: - Discovery Lead Optimization - in vivo ph ... more
Developing tiny probes for research and brain-related medical applications – that is the goal of the project NeuroSeeker, launched in February 2013 with a kick-off event in Leuven. The interdisciplinary project pools the expertise of ten partner institutions from Europe and Canada. The Univ ... more
ElexoPharm Receives € 2.1 Million EUROSTARS Grant
A EUROSTARS grant of €2.1 million has been awarded to a transnational consortium consisting of Khondrion BV ( Nijmegen), Radboud University Nijmegen Medical Centre (RUNMC, Nijmegen), Pharmacelsus GmbH (Saarbruecken) and ElexoPharm GmbH (Saarbruecken). This grant, which for the German partne ... more
Greater Accuracy in Gauging Blood Coagulation
Thrombin plays a key role in various pathologies of the haemostatic system. Overexpression of thrombin can result in thrombosis, whereas its underexpression might lead to haemophilia. Therefore, accurate monitoring of thrombin activity is crucial for determining the proper treatment of a gi ... more
Radboud University Nijmegen Medical Centre is a leading academic centre with expertise in medical science and healthcare. Expertise plays an essential part in our organisation and connects research, education and patient care. Our more than 8,500 staff and 3,000 students are committed and a ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
